{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:55:51Z","timestamp":1787068551358,"version":"build-2736575974"},"reference-count":49,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T00:00:00Z","timestamp":1749859200000},"content-version":"am","delay-in-days":348,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U01CA233102-01"],"award-info":[{"award-number":["U01CA233102-01"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P01CA250972"],"award-info":[{"award-number":["P01CA250972"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["T32CA009206"],"award-info":[{"award-number":["T32CA009206"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P50CA278595"],"award-info":[{"award-number":["P50CA278595"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004340","name":"Siemens USA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004340","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011983","name":"American Radium Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011983","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006775","name":"GE Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001395","name":"Wisconsin Alumni Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001395","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.ijrobp.2024.02.005","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T08:56:50Z","timestamp":1708073810000},"page":"1275-1284","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Voxel-Level Dosimetry for Combined Iodine 131 Radiopharmaceutical Therapy and External Beam Radiation Therapy Treatment Paradigms for Head and Neck Cancer"],"prefix":"10.1016","volume":"119","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8282-6660","authenticated-orcid":false,"given":"David P.","family":"Adam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph J.","family":"Grudzinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian R.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve Y.","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler J.","family":"Bradshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarrod","family":"Longcor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Burr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine Y.","family":"Bruce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Harari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan P.","family":"Bednarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2024.02.005_bib0001","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41573-020-0073-9","article-title":"Radiopharmaceutical therapy in cancer: Clinical advances and challenges","volume":"19","author":"Sgouros","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ijrobp.2024.02.005_bib0002","first-page":"12S","article-title":"Tumor response to radiopharmaceutical therapies: The knowns and the unknowns","volume":"62","author":"Sgouros","year":"2021","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijrobp.2024.02.005_bib0003","doi-asserted-by":"crossref","first-page":"23S","DOI":"10.2967\/jnumed.121.262751","article-title":"Normal-tissue tolerance to radiopharmaceutical therapies, the knowns and the unknowns","volume":"62","author":"Wahl","year":"2021","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijrobp.2024.02.005_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/14736691211060117","article-title":"ICRU Report 96, dosimetry-guided radiopharmaceutical therapy","volume":"21","author":"Sgouros","year":"2021","journal-title":"J ICRU"},{"key":"10.1016\/j.ijrobp.2024.02.005_bib0005","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1002\/cncr.23654","article-title":"Head and neck cancer: An evolving treatment paradigm","volume":"113","author":"Cognetti","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2024.02.005_bib0006","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1056\/NEJMc073274","article-title":"Treatment of head and neck cancer","volume":"358","author":"Forastiere","year":"2008","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ijrobp.2024.02.005_bib0007","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1200\/JCO.2009.27.4498","article-title":"Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: Results from TROG 02.02","volume":"28","author":"Peters","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.02.005_bib0008","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients","volume":"92","author":"Pignon","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.02.005_bib0009","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.ijrobp.2011.06.1998","article-title":"Practical considerations in the re-irradiation of recurrent and second primary head-and-neck cancer: Who, why, how, and how much?","volume":"81","author":"Chen","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.02.005_bib0010","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1016\/j.ijrobp.2011.01.004","article-title":"Reirradiation for head-and-neck cancer: Delicate balance between effectiveness and toxicity","volume":"81","author":"Hoebers","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.02.005_bib0011","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.oraloncology.2004.07.006","article-title":"A review on re-irradiation for recurrent and second primary head and neck cancer","volume":"41","author":"Kasperts","year":"2005","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ijrobp.2024.02.005_bib0012","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/hed.20163","article-title":"Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies","volume":"27","author":"Kramer","year":"2005","journal-title":"Head Neck"},{"key":"10.1016\/j.ijrobp.2024.02.005_bib0013","doi-asserted-by":"crossref","first-page":"4800","DOI":"10.1200\/JCO.2006.07.9194","article-title":"Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: Results of Radiation Therapy Oncology Group Protocol 9911","volume":"25","author":"Langer","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.02.005_bib0014","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/COC.0b013e3181637398","article-title":"Re-irradiation of head and neck carcinoma","volume":"31","author":"Mendenhall","year":"2008","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.02.005_bib0015","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ijrobp.2005.07.005","article-title":"Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma","volume":"64","author":"Salama","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.02.005_bib0016","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.ijrobp.2006.01.054","article-title":"Impact of conventional radiotherapy on health-related quality of life and critical functions of the head and neck","volume":"65","author":"Connor","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.02.005_bib0017","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.radonc.2015.06.015","article-title":"Therapeutic combination of radiolabeled CLR1404 with external beam radiation in head and neck cancer model systems","volume":"116","author":"Morris","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.02.005_bib0018","doi-asserted-by":"crossref","first-page":"e414","DOI":"10.1016\/S1470-2045(17)30379-0","article-title":"Targeted radionuclide therapy in combined-modality regimens","volume":"18","author":"Gill","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2024.02.005_bib0019","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.clon.2021.09.004","article-title":"Combining external beam radiation and radionuclide therapies: Rationale, radiobiology, results and roadblocks","volume":"33","author":"Abbott","year":"2021","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.02.005_bib0020","unstructured":"CLR 131 combined with radiation for head and neck cancer. ClinicalTrials.gov identifier: NCT04105543. Updated January 25, 2024. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04105543 Accessed May 3, 2020"},{"key":"10.1016\/j.ijrobp.2024.02.005_bib0021","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007646","article-title":"Alkylphosphocholine analogs for broad-spectrum cancer imaging and therapy","volume":"6","author":"Weichert","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ijrobp.2024.02.005_bib0022","first-page":"458","article-title":"Targeting of head and neck cancer by radioiodinated CLR1404 in murine xenograft tumor models with partial volume corrected theranostic dosimetry","volume":"38","author":"Marsh","year":"2023","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.ijrobp.2024.02.005_bib0023","first-page":"227","article-title":"Planning combined treatments of external beam radiation therapy and molecular radiotherapy","volume":"29","author":"Cremonesi","year":"2014","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.ijrobp.2024.02.005_bib0024","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20150042","article-title":"Improving external beam radiotherapy by combination with internal irradiation","volume":"88","author":"Dietrich","year":"2015","journal-title":"Brit J Radiol"},{"key":"10.1016\/j.ijrobp.2024.02.005_bib0025","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.ijrobp.2010.08.022","article-title":"A treatment planning method for sequentially combining radiopharmaceutical therapy and external radiation therapy","volume":"80","author":"Hobbs","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.02.005_bib0026","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.2967\/jnumed.113.122390","article-title":"MIRD pamphlet No. 24: Guidelines for quantitative 131I SPECT in dosimetry applications","volume":"54","author":"Dewaraja","year":"2013","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijrobp.2024.02.005_bib0027","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.1002\/mp.15699","article-title":"Validation of Monte Carlo 131I radiopharmaceutical dosimetry workflow using a 3D-printed anthropomorphic head and neck phantom","volume":"49","author":"Adam","year":"2022","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2024.02.005_bib0028","first-page":"155","article-title":"Development and validation of RAPID: A patient-specific Monte Carlo three-dimensional internal dosimetry platform","volume":"33","author":"Besemer","year":"2018","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.ijrobp.2024.02.005_bib0029","first-page":"632","article-title":"3D Slicer","volume":"1","author":"Pieper","year":"2004","journal-title":"Proc IEEE Int Symp Biomed Imaging"},{"key":"10.1016\/j.ijrobp.2024.02.005_bib0030","doi-asserted-by":"crossref","DOI":"10.1118\/1.4901409","article-title":"Deformable image registration based automatic CT-to-CT contour propagation for head and neck adaptive radiotherapy in the routine clinical setting","volume":"41","author":"Kumarasiri","year":"2014","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2024.02.005_bib0031","series-title":"Center for High Throughput Computing","year":"2006"},{"key":"10.1016\/j.ijrobp.2024.02.005_bib0032","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.clon.2006.09.008","article-title":"Is there an optimum overall time for head and neck radiotherapy? A review, with new modelling","volume":"19","author":"Fowler","year":"2007","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.02.005_bib0033","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0167-8140(95)01689-9","article-title":"Repair capacity and kinetics for human mucosa and epithelial tumors in the head and neck: Clinical data on the effect of changing the time interval between multiple fractions per day in radiotherapy","volume":"38","author":"Bentzen","year":"1996","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.02.005_bib0034","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.ijrobp.2008.11.039","article-title":"Sensitivity analysis of parameters in linear-quadratic radiobiologic modeling","volume":"73","author":"Fowler","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.02.005_bib0035","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0167-8140(99)00151-6","article-title":"Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer","volume":"53","author":"Bentzen","year":"1999","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.02.005_bib0036","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1667\/RR13483.1","article-title":"Redefining relative biological effectiveness in the context of the EQDX formalism: Implications for alpha-particle emitter therapy","volume":"181","author":"Hobbs","year":"2014","journal-title":"Radiat Res"},{"key":"10.1016\/j.ijrobp.2024.02.005_bib0037","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1118\/1.3070587","article-title":"Calculation of the biological effective dose for piecewise defined dose-rate fits","volume":"36","author":"Hobbs","year":"2009","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2024.02.005_bib0038","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1002\/mp.14143","article-title":"New capabilities of the Monte Carlo dose engine ARCHER-RT: Clinical validation of the Varian TrueBeam machine for VMAT external beam radiotherapy","volume":"47","author":"Adam","year":"2020","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2024.02.005_bib0039","doi-asserted-by":"crossref","first-page":"6332","DOI":"10.1118\/1.4754659","article-title":"SlicerRT: Radiation therapy research toolkit for 3D Slicer","volume":"39","author":"Pinter","year":"2012","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2024.02.005_bib0040","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1118\/1.3582690","article-title":"Dosimetric comparison of Acuros XB deterministic radiation transport method with Monte Carlo and model-based convolution methods in heterogeneous media","volume":"38","author":"Han","year":"2011","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2024.02.005_bib0041","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.1088\/0031-9155\/51\/19\/015","article-title":"Clinical comparison of head and neck and prostate IMRT plans using absorbed dose to medium and absorbed dose to water","volume":"51","author":"Dogan","year":"2006","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ijrobp.2024.02.005_bib0042","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.phro.2019.08.005","article-title":"Dose to medium in head and neck radiotherapy: Clinical implications for target volume metrics","volume":"11","author":"Hardcastle","year":"2019","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.02.005_bib0043","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejmp.2018.10.024","article-title":"Dosimetric impact of Acuros XB dose-to-water and dose-to-medium reporting modes on VMAT planning for head and neck cancer","volume":"55","author":"Mu\u00f1oz-Montplet","year":"2018","journal-title":"Phys Med"},{"key":"10.1016\/j.ijrobp.2024.02.005_bib0044","first-page":"123","article-title":"Characterization of scatter and penetration using Monte Carlo simulation in 131I imaging","volume":"41","author":"Dewaraja","year":"2000","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijrobp.2024.02.005_bib0045","first-page":"77","article-title":"Monte Carlo modeling of gamma cameras for I-131 imaging in targeted radiotherapy","volume":"20","author":"Autret","year":"2005","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.ijrobp.2024.02.005_bib0046","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/acm2.12957","article-title":"An international survey on the clinical use of rigid and deformable image registration in radiotherapy","volume":"21","author":"Yuen","year":"2020","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.ijrobp.2024.02.005_bib0047","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cmpb.2017.11.001","article-title":"An automated dose tracking system for adaptive radiation therapy","volume":"154","author":"Liu","year":"2018","journal-title":"Comput Methods Programs Biomed"},{"issue":"suppl 1","key":"10.1016\/j.ijrobp.2024.02.005_bib0048","first-page":"99S","article-title":"Patient-specific dosimetry in predicting renal toxicity with (90)Y-DOTATOC: Relevance of kidney volume and dose rate in finding a dose-effect relationship","volume":"46","author":"Barone","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijrobp.2024.02.005_bib0049","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.2967\/jnumed.108.053173","article-title":"MIRD pamphlet no. 20: The effect of model assumptions on kidney dosimetry and response - implications for radionuclide therapy","volume":"49","author":"Wessels","year":"2008","journal-title":"J Nucl Med"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301624003080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301624003080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T14:49:50Z","timestamp":1777560590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301624003080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0360301624003080"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.02.005","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Voxel-Level Dosimetry for Combined Iodine 131 Radiopharmaceutical Therapy and External Beam Radiation Therapy Treatment Paradigms for Head and Neck Cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}